Physician
Primary Care Health Partners - New York LLP
Primary Care Health Partners - New York LLP was paid $3.22M by Medicaid between Jan 2018 and Nov 2024, across 43 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 50% of everything it billed.
33Billing provider infoPRIMARY CARE HEALTH PARTNERS - NEW YORK LLP
PLATTSBURGH, NY 12901
PLATTSBURGH, NY 12901
33aNPI1003861782assigned 05/23/2006
33bProvider typePediatrics Physician
28Total paid$3.22M
24GClaims63,815
24DCodes billed43
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Pediatrics Physician providers in New York
Rank by total paid#102 of 1,983
Median peer was paid$17K
This provider vs. median190×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,298 | $257K | |
| 2019 | 10,565 | $442K | |
| 2020 | 9,934 | $424K | |
| 2021 | 8,496 | $481K | |
| 2022 | 10,346 | $553K | |
| 2023 | 10,557 | $571K | |
| 2024incomplete | 8,619 | $492K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 50% | 20,169 | 18,227 | $1.60M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 18% | 4,965 | 4,568 | $568K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 8.7% | 2,770 | 2,770 | $279K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 7.3% | 6,763 | 6,751 | $234K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.0% | 1,895 | 1,895 | $193K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 4.2% | 1,233 | 1,233 | $136K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.9% | 963 | 958 | $92K |
| 96127 | 1.1% | 6,962 | 6,282 | $34K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 955 | 910 | $21K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 350 | 349 | $18K |
| 99051 | <1% | 1,714 | 1,679 | $9K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 150 | 149 | $8K |
31 more codes
| 92551 | <1% | 1,047 | $8K | |
| 96160 | <1% | 2,511 | $4K | |
| 80061 | Lipid panel | <1% | 334 | $4K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 339 | $4K |
| 90473 | <1% | 235 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 188 | $2K |
| 99383 | <1% | 13 | $1K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 34 | $1K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 198 | $637.74 |
| 83655 | <1% | 42 | $539.64 | |
| 96161 | <1% | 173 | $474.87 | |
| 85018 | <1% | 221 | $469.97 | |
| 87634 | <1% | 12 | $259.68 | |
| 99173 | <1% | 478 | $81.51 | |
| 81003 | <1% | 26 | $57.69 | |
| 99000 | 0% | 4,047 | $0.00 | |
| 36416 | 0% | 1,445 | $0.00 | |
| 94760 | 0% | 73 | $0.00 | |
| 90660 | 0% | 55 | $0.00 | |
| 90686 | 0% | 1,894 | $0.00 | |
| 90680 | 0% | 143 | $0.00 | |
| 90647 | 0% | 198 | $0.00 | |
| 90656 | 0% | 107 | $0.00 | |
| A7015 | Aerosol mask, used with dme nebulizer | 0% | 71 | $0.00 |
| 90677 | 0% | 60 | $0.00 | |
| 90723 | 0% | 148 | $0.00 | |
| 90670 | 0% | 272 | $0.00 | |
| 90672 | 0% | 505 | $0.00 | |
| 90734 | 0% | 29 | $0.00 | |
| 98960 | 0% | 13 | $0.00 | |
| 90671 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialASSELIN, JON (COO)
| Provider | Location | Paid |
|---|---|---|
| Primary Care Health Partners - Vermont LLP | Williston, VT | $2.76M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.